Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALSUntangled recommends avoiding the Stowe/Morales ALS Protocol

Original source

The Stowe/Morales ALS ProtocolALSUntangled · 15 June 2010 (opens in a new tab)

ALSUntangled strongly recommends that people with ALS avoid the Stowe/Morales ALS Protocol. It says the protocol is extremely expensive and is based on an unsound rationale. The review describes its treatments as unclear, disproven, or potentially harmful, and says valid outcome measures are not being followed.【S1】

Why this matters

This is relevant to people with ALS considering the protocol, because the review advises against using it and raises concerns about cost, evidence, safety, and how outcomes are assessed. The source does not establish that the protocol benefits patients or changes ALS treatment.【S1】

Limitations and context

This assessment comes from one independent ALSUntangled expert review published in 2010, not a newly reported clinical trial. The source does not provide detailed study results, participant numbers, or evidence of treatment effectiveness. Its statements about the protocol should therefore be understood as the review’s assessment.【S1】

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?